Evidence map›Paper›PMID 41023686›Full record

ArticleBMC cancer2025

Non-truncating BMPR1A variants associated with familial colorectal cancer and adenomatous polyps.

Taina T Nieminen, Outi Kuismin, Riitta Laine, Anna Lepistö, Laura Koskenvuo, Laura Renkonen-Sinisalo, Markus J Mäkinen, Ari Ristimäki, Jukka-Pekka Mecklin, Päivi Peltomäki

Abstract read
In one paragraph

Article in BMC cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Case Report:Frontiers in oncology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Taina T NieminenDepartment of Medical and Clinical Genetics, Medicum, University of Helsinki, Helsinki, Finland. taina.nieminen@helsinki.fi.
Outi KuisminDepartment of Clinical Genetics, Research Unit of Clinical Medicine, Medical Research Center Oulu, Oulu University Hospital, University of Oulu, Oulu, Finland.
Riitta LaineDepartment of Clinical Genetics, Research Unit of Clinical Medicine, Medical Research Center Oulu, Oulu University Hospital, University of Oulu, Oulu, Finland.
Anna LepistöDepartment of Abdominal Surgery, Helsinki University Hospital, Helsinki, Finland.
Laura KoskenvuoDepartment of Abdominal Surgery, Helsinki University Hospital, Helsinki, Finland.
Laura Renkonen-SinisaloDepartment of Abdominal Surgery, Helsinki University Hospital, Helsinki, Finland.
Markus J MäkinenTranslational Medicine Research Unit, Medical Research Center Oulu, Oulu University Hospital, University of Oulu, Oulu, Finland.
Ari RistimäkiApplied Tumor Genomics, Research Programs Unit, University of Helsinki, Helsinki, Finland.
Jukka-Pekka MecklinDepartment of Education & Research, The Wellbeing Services of Central Finland, Jyväskylä, Finland.
Päivi PeltomäkiDepartment of Medical and Clinical Genetics, Medicum, University of Helsinki, Helsinki, Finland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPathogenic variants of the bone morphogenetic protein receptor type 1 A (BMPR1A) gene underlie juvenile polyposis syndrome (JPS), a rare autosomal dominant condition characterized by multiple gastrointestinal hamartomatous polyps. Recent findings indicate that constitutional BMPR1A variants can also be associated with various non-JPS phenotypes without hamartomatous polyps. The basis of varying genotype - phenotype relationships is poorly understood.

methodsWe investigated four families with non-truncating variants of BMPR1A affecting different functional domains. Clinical presentation resembled familial colorectal cancer type X-like syndrome with dominantly inherited microsatellite-stable gastrointestinal adenomas and carcinomas. To gain insights into genotype-phenotype associations, exome sequencing was conducted on normal and tumor tissue DNAs. Constitutional BMPR1A variants underwent a thorough evaluation for clinical significance, by, e.g., co-segregation analyses and in silico modeling, supplemented by haplotyping and genealogical studies. All available tumors were examined for histology and molecularly for BMPR1A "second hits" and mutational signatures.

resultsTargeted sequencing of blood DNA revealed a three-nucleotide deletion (BMPR1A c.264_266 del) in one family, a three-nucleotide insertion (BMPR1A c.506_507insTCC) in two families, and a missense change (BMPR1A c.766G > A) in a fourth family. The two families with BMPR1A c.506_507insTCC had a shared ancestral origin. Co-segregation of the variants with colorectal cancer and/or polyps, in-silico modeling, and two hit inactivation by loss of heterozygosity or somatic point mutations in tumors, together with the absence of other possible predisposing variants by exome sequencing, supported the idea of tumor predisposition being attributable to the BMPR1A variants. Polyps examined from variant carriers had adenomatous histology, except for three polyps with hamartomatous features, originating from two BMPR1A carriers from two families. While no hamartoma samples were available for molecular investigation, somatic mutational profiles of colorectal adenomas and carcinomas resembled those of mismatch repair-proficient colorectal tumors in general.

conclusionsOur findings support the notion that the clinical phenotype of BMPR1A variants may extend beyond classical JPS. Genotype-phenotype correlations are complex, since molecular comparison of constitutional and tumor features of our families to those published from JPS families in the literature show a significant overlap. The variety of clinical phenotypes warrants recognition in the clinical management of BMPR1A carriers and their family members.

Indexed as

Adenomatous PolypsBone Morphogenetic Protein Receptors, Type IColorectal NeoplasmsAdultAgedExome SequencingFemaleGenetic Association StudiesGenetic Predisposition to DiseaseHumansIntestinal PolyposisMaleMiddle AgedMutationNeoplastic Syndromes, HereditaryPedigreeBMPR1A protein, humanBone Morphogenetic Protein Receptors, Type IAdenomatous polypBMPR1AColorectal cancerFamilial colorectal cancer type xJuvenile polyposis syndrome

Identifiers

PMID41023686
PMCPMC12481737

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.